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The Role of Bullous Pemphigoid Antibodies III Dermal-epidermal Separation 
To the Editor: 
We refer to the article of Gammon and Briggman 11 J, who reported 
on the absence of specific histologic changes in guinea pig skin 
treated with bullous pemphigoid (bP) antibodies. This lener is to 
draw attention to our studies on the same subject published in 1984 
and 1985 [2.3]. 
In the firSt asS2Y we injected 0.1, 0.2, or 0.3 ml of the followin~ 
preparations into the skin ofbP patients (n = 9, autologous system) 
in the inactive stage of the disease (maintenance dosis of predniso-
lone < 10 rng/ d): I ) blister fl uid; 2} supernatand of the blister fluid 
{bP antibody titer 20 to 640}; 3) cell sedimellt {200 Gpt/ I}; 4} 
supernatand plus au to logous granulocytes (200 Gpt/I); 5) IgG from 
serum (DEAE-sephandex A-50 with 0.01 mol/ I phosphate buffer 
pH 6.5, antibody titer 20 to 2560, protein concentration 10 g/ 1. 
This fraction did not contain any protease inhibitors); 6) natrium 
chloride, 0.9% solution. 
Diistet fluid and se ra were kept frozen at -70°C . . Biopsies were 
taken after 6, 12,24,48. and 72 h and studied by routine histology 
and direct immunofluorescence {IF}. In 50%-84% all the prepara-
tions (except the control) induced a delayed sl ight erythema up to 
30 h. but no bl ister forma tion. Histologic and IF findings (IgG , Cl) 
were negative without any signs of dennal-epidermal separation. In 
the minority of biopsies slight transient perivascular infiltrates of 
mononuclear ce lls with a few granulocytes were seen in the dermis. 
Obviously, after their loose and temporary binding to bP antigen (of 
minor accessibility), the dissociation of the bP antibody (of low 
aRinity?) took place very soon in this in vivo model. 
In a second assay we used skin explants (n - 10) of3 X 3 mm in 
size and 1.5 -2 mill in thickness. They were incubated on collagen 
gel at 35°C and 98% to 100% humidity in COl atmosphere and 
were exposed (Q the following preparations: 1) Eagle medium; 2) 
normal se rum; 3} bP se rum (titer 160 to 1280); 4} IgG from bP 
serum {titer 20 to 2560}; 5} blister fluid ; 6) bP se rum and normal 
serum (as complement source) and granulocytes (200 Gpt/ l ) 
In this in vitro assay we could show that blister fluid ofbP, as well 
as bP sera together with complement and neutrophil s, were able to 
produce a dermal-epidermal separation after 24-48 h. Obviously 
the binding of the bP antibody to the bP antigen is necessary before 
the separation (already after 6 h) . Using a skin split technique we 
showed that all bP antibodies reacted with the epidermal side (roof) 
of the separation consistent with antilamina lucida antibodies. The 
intensity of IF depended on both the titer of the bP antibodies and 
the incubation period (lgG, C3). The decrease in the intensity ob-
served afrer more than 24 h ofincubation might be due todegenera-
tive processes at the dermal-epidermal junction under the tissue 
culture conditions. Apparently, in addition to bP antibody, other 
factors such as complement and neutrophils (proteinase) are in-
volved in this mechanism. The effect was abo lished by heating orby 
the proteinase h inhibitor a 2 macroglobulin, but not by at an titryp-
sin or at antichymotrypsin, in ag reement with Nito et al. [4.5}. 
W e have no ex perience with guinea pigs. We wonder, however, 
how Gammon and Briggman (1) found no difference in the inci-
dence of dermal-epidermal separa tion or type of inflammation in 
experimemal and control si res and no correlation to rhe deposition 
of immune reactants at the basement membrane zone (DMZ). The 
latter might be explained to a minor degree by differences in the 
affinity and complement activating properties of the bP antibodies, 
as well as by the fast c1earanc(' of the antibodies. Additionally, in 
agreement with Gammon and Driggman 11]. we favor the hypoth-
esis that much of the bP antigen in viable intact skin is intracellular 
and therefore inaccessible to speci fic antibodies, as underlined by 
our in vi tro studies with ski n explants. 
The question of why cotnrol sera are able to induce a der.nal-epi-
dermal separa tion remains, however, unclear. We did not inject 
control se ra in(Q humans for ethical reasons. However. we would 
not have expected any posi tive reaction. Mechanical and hydroS[atic 
trauma arc less likely than the effect of proteases. In conclusion. 
from th e data discussed in the literature and presented here, we 
think that bP antibodies playa major role in the complex ity of 
pathogenetic events of bP. 
Uwe-Frithjof Haustein, M.D. 
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